ONO-7746 Study in Healthy Adult Subjects

Ono Pharmaceuticals

Status and phase: Completed; Phase 1

Conditions: Healthy Adult Subjects

Treatments: Drug: ONO-7746

Study type: Interventional

Funder types: Industry

Identifiers

NCT00956371

ONO-7746POU001

Details and patient eligibility

About

The primary objective of this study is to evaluate the safety and tolerability of ONO-7746 in healthy adult subjects. The secondary objectives are to characterize the pharmacokinetic and pharmacodynamic profiles of ONO-7746.

Enrollment: 48 patients

Sex: All

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy non-smoking male or female subjects (18-55 years inclusive)
• Body mass index (BMI) of 19-35 kg/m² (inclusive)
• For females: postmenopausal, non-lactating and non-pregnant

Exclusion criteria

• History or presence of clinically significant disease

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

48 participants in 2 patient groups, including a placebo group

P

Placebo Comparator group

Treatment:

Drug: ONO-7746

Drug: ONO-7746

E

Experimental group

Treatment:

Drug: ONO-7746

Drug: ONO-7746